Clinical Trial Update: APACC Study:Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma Recurrence [Phase 3]

View source ↗

Summary

The Phase 3 APACC trial evaluating aspirin to reduce colorectal adenoma recurrence has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenomas

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Colon Adenomas | Phase 3 | Status: TERMINATED